Your Top 50 most-cited badge
A badge for your website, a sentence for your CV, and a permanent page where anyone can check the rank.
The article
Bimekizumab maintenance of response through 3 years in patients with moderate-to-severe plaque psoriasis: results from the BE BRIGHT open-label extension trial
Bruce E Strober, Yayoi Tada, Ulrich Mrowietz, Mark Lebwohl, Peter T. Foley, Richard G B Langley and 6 more
- Rank
- 23 of 545
- Percentile
- top 4.3%
- Where
- British Journal of Dermatology, 2023
- Citations
- 45
From the 2023 list, OpenAlex counts as of 2026-10-29.
Prefer not to be listed? The same link lets you withhold your name on every list; the article stays, your name does not. Questions: team@avidnote.com.